Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multi-Center Extension Study Of Probuphine in Patients With Opioid Dependence

NCT00630201 is registered in ClinicalTrials.gov with Titan Pharmaceuticals as lead sponsor.

NCT NCT00630201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00630201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multi-Center Extension Study Of Probuphine in Patients With Opioid Dependence
Lead sponsor
Titan Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
February 28, 2009
Enrollment
62 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependence